Ezetimibe Reduces Low-Density Lipoprotein Cholesterol (LDL-C) in Renal Transplant Patients Resistant to HMG-CoA Reductase Inhibitors
Authors:
- Peale ChuangPCPeale Chuang
- Anthony J LangoneALAnthony J Langone
- 1 September 2007
- journal article
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 14 (5) , 438-441
Abstract
Hyperlipidemia is common after renal transplantation. On the basis of current lipid guidelines, the majority of renal transplant recipients should have plasma low-density lipoprotein cholesterol (LDL-C) levels 100 mg/dL. We report that ezetimibe, a novel inhibitor of intestinal cholesterol absorption, was well tolerated and effectively reduced the LDL-C level to <100 mg/dL in our cohort of renal transplant recipients with persistently elevated LDL-C levels during treatment with maximally tolerated statin medications.Keywords
This publication has 21 references indexed in Scilit:
- Patient-Specific Prompts in the Cholesterol Management of Renal Transplant Outpatients: Results and Analysis of UnderperformanceTransplantation, 2004
- A long‐term study on hyperlipidemia in stable renal transplant recipientsClinical Transplantation, 2004
- Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trialThe Lancet, 2003
- Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary HypercholesterolemiaCirculation, 2003
- Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemiaEuropean Heart Journal, 2003
- Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemiaThe American Journal of Cardiology, 2002
- Effect of pravastatin treatment on the evolution of extracoronary atherosclerosis in renal transplant patientsTransplantation Proceedings, 2002
- Effects of cerivastatin in dyslipemia and other cardiovascular risk factors after renal transplantationTransplantation Proceedings, 2002
- IMPACT OF SERUM LIPIDS ON LONG-TERM GRAFT AND PATIENT SURVIVAL AFTER RENAL TRANSPLANTATION1Transplantation, 1995
- THE EFFECTS OF PRAVASTATIN ON HYPERLIPIDEMIA IN RENAL TRANSPLANT RECIPIENTS1Transplantation, 1992